Resultados de búsqueda

Phase 2 Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Following Second-Line Lenalidomide (LEN)-Based Treatment (Tx) in Patients (Pts) With Relapsed or Refractory Mul... por Siegel, David S., Schiller, Gary J., Song, Kevin, Agajanian, Richy, Stockerl-Goldstein, Keith, Kaya, Hakan, Sebag, Michael, Reu, Frederic J., Malek, Eshan, Mouro, Jorge, Chung, Weiyuan, Srinivasan, Shankar, Qian, Max, Rizvi, Syed, Thakurta, Anjan, Bahlis, Nizar J.

Ver este registro en EBSCOhost

Predictors of Treatment (tx) with Triplet First-Line Therapy (1LT) among Transplant-Ineligible Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) in Routine Clinical Care. por Romanus, Dorothy, Raju, Aditya, Seal, Brian, Farrelly, Eileen, Luptakova, Katarina, Blazer, Marlo, Parameswaran, Hari

Ver este registro en EBSCOhost

Treatment (tx) Patterns & Outcomes by Line of Therapy (LOT) in a Large United States (US) Cohort of Transplant-Ineligible Patients (pts) with Multiple Myeloma in the Era of Novel A... por Romanus, Dorothy, Raju, Aditya, Seal, Brian, Farrelly, Eileen, Noga, Stephen J., Blazer, Marlo, Parameswaran, Hari

Ver este registro en EBSCOhost

Newly Diagnosed Multiple Myeloma (NDMM): Effect of Age, Renal Insufficiency (RI), & Cardiovascular (CV) Disease (dz) on Overall Survival (OS) & Treatment (tx) Patterns Among Stem C... por Romanus, Dorothy, Raju, Aditya, Seal, Brian, Farrelly, Eileen, Skacel, Tomas, Blazer, Marlo, Parameswaran, Hari

Ver este registro en EBSCOhost

Nanotechnology may advance skin cancer Tx. por PETROU, ILYA

Ver este registro en EBSCOhost

Medical innovation expands hair loss Tx. por GUTTMAN KRADER, CHERYL

Ver este registro en EBSCOhost

Combination Tx, patient ed keys to optimize care. por GUTTMAN KRADER, CHERYL

Ver este registro en EBSCOhost

Re-think rescue Tx: Consider options to target pathophysiology. por HILTON, LISETTE

Ver este registro en EBSCOhost

Author's Response to Letter to the Editor by Dunlei Cheng, PhD, Biostatistician Institute for Health Care Research and Improvement, Baylor Health Care System, Dallas, TX. por Williams, Arthur R., Messmer, Patricia R., Hill-Rodriguez, Deborah, Williams, Phoebe D.

Ver este registro en EBSCOhost

First Report®. American Academy of Pain Medicine 2010 Annual Meeting, San Antonio, TX; February 3-6, 2010.

Ver este registro en EBSCOhost

Final STEPP results of prophylacatic versus reactive skin toxicity (ST) treatment (tx) for panitumumab (pmab)-related ST in patients (pts) with metastatic colorectal cancer (mCRC). por Mitchell, E P, Lacouture, M, Shearer, H, Iannotti, N, Piperdi, B, Pillai, M, Xu, F, Yassine, M

Ver este registro en EBSCOhost

Long-term safety of sorafenib (SOR) for the treatment (tx) of advanced clear-cell renal-cell carcinoma (RCC): Data analysis from patients (pts) treated for over 1 year in the phase... por Hutson, T E, Bellmunt, J, Porta, C, Staehler, M, Szczylik, C, Nadel, A, Anderson, S, Bukowski, R M, Eisen, T, Escudier, B

Ver este registro en EBSCOhost

Clinical course of advanced non-small cell lung cancer (NSCLC) patients (pts) experiencing hypertension (HTN) during treatment (TX) with bevacizumab (B) in combination with carbopl... por Dahlberg, S E, Sandler, A B, Brahmer, J R, Schiller, J H, Johnson, D H

Ver este registro en EBSCOhost

Treatment (tx) with tyrosine kinase inhibitors (TKIs) for patients (pts) with differentiated thyroid cancer (DTC): The M. D. Anderson Cancer Center (MDACC) experience. por Cabanillas, M E, Waguespack, S G, Bronstein, Y, Williams, M, Feng, L, Sherman, S I, Busaidy, N L

Ver este registro en EBSCOhost

A retrospective chart review study of relapsed or refractory multiple myeloma (MM) patients (Pts): A look into historical treatment (Tx) patterns. por Zaman, F, Reece, D E, Teixeira, B L, Yoong, K, Camacho, F, Plante, R K

Ver este registro en EBSCOhost

Current treatment (Tx) patterns in relapsed or refractory multiple myeloma (MM): A retrospective chart review study. por Reece, D E, Zaman, F, Teixeira, B L, Yoong, K, Camacho, F, Plante, R K

Ver este registro en EBSCOhost

A phase Ib/II trial of AMG 655 and panitumumab (pmab) for the treatment (tx) of metastatic colorectal cancer (mCRC): Safety results. por Rougier, P, Infante, J, Van Laethem, J, Stephenson, J J, Uronis, H, Schwartzberg, L, Chen, L, Wu, C, Smethurst, D, Peeters, M

Ver este registro en EBSCOhost

Gain study: A phase III trial to compare ETC versus EC-TX and ibandronate versus observation in patients with node-positive primary breast cancer. por Möbus, V, Conrad, B, Schneeweis, A, Kreienberg, R, Solomayer, E F, Clemens, M R, Tesch, H, Loibl, S, Nekljudova, V, von Minckwitz, G

Ver este registro en EBSCOhost

Day surgery has added benefits for children (Dallas, TX. Children's Med Center) por Lee RM

Ver este registro en EBSCOhost

Day surgery: a concept of care for the pediatric patient (Dallas, TX. Children's Med Center) por Bell A

Ver este registro en EBSCOhost